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Interleukin (IL)-3-like bioactivity has been found in 
culture supernatants frOtn hutnan and tnurine kera-
tinocytes. However, there is controversy as to the 
presence of IL-3 tnRNA in hutnan keratinocytes. 
Using highly sensitive reverse transcription-poly-
tnerase chain reaction and enzytne-linked itntnU-
nosorbent assay techniques, we exatnined hutnan 
keratinocytes frotn four different donors (neonatal 
foreskins) and were unable to detect IL-3 tnRNA or 
IL-3 protein. Despite successful atnplification of 
DNA frOtn an IL-3 cDNA, no product could be ob-
tained by atnplification of keratinocyte RNA treated 
with reverse transcription-polytnerase chain reac-
tion. Analysis of concentrated (up to 50-fold) super-
natants failed to detect IL-3 protein by enzytne-
linked itntnunosorbent assay. Because ultraviolet 
radiation up-regulates tnany cytokines, we irradiated 
hutnan keratinocytes with 300 J/tn2 ultraviolet Band 
collected supenlatants 24 h post-irradiation. Super-
natants concentrated 50-fold were also negative for 
IL-3 protein by enzytne-linked itntnunosorbent assay. 
When assayed on the IL-3-responsive M-07e cell line, 
unirradiated supernatants stitnulated M-07 e prolifer-
ation 22-fold over background levels. Irradiated su-
nterleukin (IL)-3 was originally described as a colony-
forming-unit-stimulating factor released from phytohemag-
glutinin-stimulated murine T cells [1] and was defined as a 
factor capable of inducing 20a-hydroxysteroid dehydroge-
nase in cultures of nu/nu splenic lymphocytes [2]. The 
human IL-3 species was identified in 1986 by Yang et al [3], and the 
gene for IL-3 has been mapped to human chromosome 5, closely 
associated with the granulocyte macrophage-colony-stimulating 
factor (GM-CSF) gene [4]. Although T cells are the major source of 
IL-3, it is also produced by activated natural killer cells [5], 
activated mast cells [6,7], the WEHI-3 myelomonocytic leukemia 
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pernatants stitnulated M-07 e proliferation 128-fold. 
Neither the unirradiated nor the irradiated superna-
tant activity could be neutralized with antibody to 
hutnan IL-3. However, incubation of irradiated su-
pernatants with antibody to granulocyte tnacro-
phage- colony-stitnulating factor (GM-CSF) reduced 
the M-07 e proliferation by 90%. Antibodies against 
GM-CSF and IL-6 cotnpletely abrogated prolifera-
tion. Reverse transcription-polytnerase chain reac-
tion confirtned a concotnitant elevation of IL-6 (2.6-
to 5.6-fold) and of GM-CSF tnRNA (2.7- to 4.3-fold) 
at 6 and 24 h after ultraviolet B irradiation in kerati-
nocytes, but no IL-3 atnplification products could be 
detected. IL-3 tnRNA was also not detected in adult 
keratinocytes. Even after stitnulation by IL-la, tutnor 
necrosis factor-a, or phobol tnyristate acetate, IL-3 
tnRNA was not detected in either neonatal or adult 
hutnan keratinocytes. We have been unable to detect 
IL-3 tnRNA or IL-3 protein in hutnan keratinocytes. 
The IL-3-like activity in hwnan keratinocytes is 
tnainly due to GM-CSF, with a small contribution 
frotn IL-6. Key words: bioassayIRT-PCRIUVBIGM-CSF. 
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cell line [8], astrocytes and neuronal cell bodies in mouse brain [9], 
and human thymic epithelial cells [10]. Keratinocyte-derived IL-3 
was first shown by Luger et al [11] to be present in the murine 
epidermal cell line Pam 212, based on the finding that conditioned 
supernatants from these cells stimulated proliferation of FDCP-1 
and 32-DCL-23, two IL-3-dependent cell lines. Antisera against 
murine T-ceU-derived IL-3 abrogated the stimulatory effects of 
Pam 212 supernatants on 32-DCL-23 cell proliferation [11], indi-
cating that the IL-3 species shared homologous epitopes. Further 
studies with Pam 212 cells and normal murine keratinocytes 
revealed that both expressed an mRNA transcript of 0.9 kilobase, 
which was homologous to the T-cell-derived IL-3 cDNA.t Thus, 
it seemed that murine keratinocytes produce IL-3. It is now 
t Ansel ]C: Expression of 11-1, and IL-3, but not !L-4 in murine 
keratinocytes (abstr). Clin Res 35:247, 1987; Kupper TS, et al: Molecular 
characterization of keratinocyte cytokines (abstr). Clin Res 35:697, 1987. 
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recognized that human IL-3 is highly species specific; however, in 
early experiments it was found that supernatants from human 
keratinocytes and keratinocyte cell lines stimulated the proliferation 
of the murine IL-3-dependent cell lines 32-DCL and FDCP-1 [12]. 
This oversight led to the conclusion that human keratinocytes 
produce IL-3. The exact nature of the 32-DCL-stimulating activity 
in human keratinocytes has not yet been identified. 
Attempts to show homology between the human epidermal cell 
IL-3 and human T-cell IL-3 by S 1 nuclease protection assay were 
unsuccessful [13]. The epidermal cell IL-3 mRNA did not protect 
the T-cell IL-3 cDNA from digestion, suggesting a lack of homol-
ogy between the molecules [14]. 
In this study, we attempted to detect IL-3 mRNA in normal 
human keratinocytes using the highly sensitive reverse transcrip-
tion-polymerase chain reaction (RT-PCR) methodology. We de-
termined IL-3 protein by IL-3-specific enzyme-linked immunosor-
bent assay (ELISA) and the M-07 e bioassay in conjunction with 
antibody blockade. In our hands, human keratinocytes do not 
express IL-3 mRNA or IL-3 protein even after ultraviolet B (UVB), 
IL-1, tumor necrosis factor-a (TNF-a) , or phorbol myristate 
acetate (PMA) stimulation. 
MATERIALS AND METHODS 
Keratinocyte Preparation and UVB Irradiation Nonnal human ke-
ratinocytes were obtained from human neonatal foreskins, as described 
previously [15,16]. Briefly, skin samples were treated with 1% dispase 
(Boehringer Mannheim, Mannheim, Gennany) solution overnight at 4°C. 
Mter treatment with trypsin (0.05%)/ethylenediamine tetra acetic acid (0.53 
mM) solution, cell suspensions were plated at 2 X 106 cells per 10-cm dish. 
Cells were maintained in keratinocyte serum-free m edium containing 
bovine pituitary extract and recombinant epidennal growth factor (Gibco 
BRL, Burlington, Ontario, Canada). UVB irradiation was carried out on 
second-passage cells using polychromatic light from a four-tube fluorescent 
sunlamp (FS20T12-UVB, National Biological Corporation, OH), which 
emits wavelengths mainly between 280-320 run, peaking at 313 run. The 
keratinocyte serum-free medium was changed to basal medium without 
bovine pituitary extract and recombinant epidennal growth factor 72 h 
before irradiation to keep the cells in a quiescent phase. Conditioned media 
were returned to the dishes after UVB irradiation. The cells were irradiated 
with 3001/m2 UVB, demonstrated previously to be optimal for induction of 
IL-1 and IL-8 in human keratinocytes [15,16]. 
Nonnal human adult keratinocytes were obtained from Clonetics Cor-
poration (San Diego, CA) and were cultured in keratinocyte growth 
medium supplemented with growth factors (complete keratinocyte growth 
medium). 
To activate keratinocytes, we used recombinant human IL-1a (Hoff-
mann-La Roche Inc., Nutley, N1), recombinant human TNF-a (Genentech 
Inc. , South San Francisco, CA), and PMA (Sigma Chemical Co., St. Louis, 
MO). 
Bioassay and ELISA for IL-3 The culture supernatants were collected 
and concentrated 50-fold using an Amicon ultrafiltration system with a 
YM-10 Diaflo membrane (Amicon Corporation, Danvers, MA) at 4°C. 
Samples were then filtered through 2-/Lm filters (Gelman Sciences Inc., Ann 
Arbor, MI) and stored at -30°C before assay. IL-3 activity was determined 
by measuring proliferation of the human megakaryoblastic leukemia cell 
line M-07e by pulse labeling with [3H]thymidine. This cell line was 
maintained as described [17,18]. It is known to respond weakly to IL-2 and 
IL-4 and strongly to GM-CSF, IL-3, IL-6, and IL-9 [17,18]. We confirmed 
that recombinant IL-3, IL-6, and GM-CSF stimulated proliferation of 
M-07e and that this could be abrogated by specific antibodies (data not 
shown). Neutralizing antibodies to human IL-3 , IL-6, and GM-CSF were 
generated by Genetics Institute (Cambridge, MA). 
ELISA was perfonned with the double-antibody sandwich method, using 
commercially available kits (Quantikine, R&D Systems, Inc., Minneapolis, 
MN). The detection limit of the kit is 7.4 pg/ml IL-3, and it does not 
cross-react with other cytokines. Each supernatant was analyzed in tripli-
cate. 
RT-PCR Total RNA was extracted from cultured keratinocytes by the 
method of Chomczynski and Sacchi (acid guanidinium thiocyanate-phenol! 
chloroform extraction) [19], and 2 /Lg of total RNA was used for the RT 
reaction. The amount of total RNA was measured by a fluorometer (Model 
450, Sequoia-Turner, CA). The RT reaction was primed with oligo dT 
[15,16], and the subsequent amplification of IL-3 was carried out using 
two kinds of specific primers: one from published sequences [20], name-
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ly, upstream,S' -ATGAGCCGCCTGCCCGTCCTGCTCCTGCTC-3', 
and downstream,S' -CATCAGAA TGTCTTGGTCTTCCCCATTGAG-
3' , which yields a 204-base pair (bp) product; and the other from Clontech 
Laboratories (Palo Alto, CA), namely, upstream, 5'-ATGAGCCGCCTGC-
CCGTCCTG-3', and downstream,S' -GCGAGGCTCAAAGTCGTCT-
GTTG-3', which yields a 449-bp product. An authentic full-length human 
T-cell-derived IL-3 eDNA (pCDSRaIL-3) (a kind gift from Dr. A. 
O'Garra, DNAX Inc.) was used as a positive control for the PCR reaction. 
The PCR reaction was performed for up to 40 cycles as follows: 1 min at 
94°C, 1 min at 60°C, and 1 min at n oc using a thennal cycler (Perkin-
Elmer/Cetus, Norwalk, CT). The PCR products were resolved on a 1.5% 
agarose gel, which was used for Southern blotting. 
Primers for human GM-CSF and IL-6 were prepared from published 
sequences [21], and glyceraldehyde-3-phosphate-dehydrogenase (G3PDH) 
primers were from Clontech Laboratories. The 5' primer was labeled 
with e2p]ATP, as described previously [15,16]. The sequences of 
specific primer pairs used in the PCR were as follows: GM-CSF 
primers, upstream,S' -TGGCTGCAGAGCCTGCTGCTC-3', and down-
stream,S' -TCACTCCTGGACTGGCTCCC-3'; IL-6 primers, upstream, 
5' -AGT AGCCGCCCCACACAGA-3 ' , and downstream, S' -CATCCA-
TCTTTTTCAGCCAT-3'; and G3PDH, upstream, 5'-TGAAGGTCG-
GAGTCAACGGATTTGGT -3' , and downstream,S' -CATGTGGGC-
CATGAGGTCCACCAC-3'. PCR products were analyzed by 
electrophoresis/autoradiography. The amplicon sizes for GM-CSF, IL-6, 
and G3PDH were 432, 190, and 983 bp, respectively, which were 
confirmed by comparison with the 100-bp molecular-size standard and with 
plasmids containing human cDNAs for GM-CSF (sp64CSFR1 AhaIII; a 
kind gift from Dr. G. Wong, Genetics Institute, MA) and IL-6 
(pBSF2.3.8.1; a kind gift from Drs. T . Hirano and T. Kishimoto, Institute 
for Molecular and Cellular Biology, Osaka University, Japan) [22 ,23]. A 
eDNA positive control for G3PDH was provided in the primer kit by 
Clontech. For each primer set, we determined the optimum Mg + + 
concentration of the PCR mixture (2.1 mM for IL-3, IL-6, and G3PDH; 1.1 
mM for GM-CSF) and annealing temperature (60°C for IL-3, GM-CSF, and 
G3PDH; 56°C for IL-6) to eliminate nonspecific signals. The linear range of 
signal strength for each cytokine mRNA was determined by perfonning 
titrations for eDNA and cycle numbers (30 cycles for GM-CSF, 32 cycles for 
IL-6, and 20 cycles for G3PDH), as described previously [15,16]. Under 
these conditions, the PCR reaction for each cytokine was not saturated. 
Each PCR product sample was size-fractionated on a 6% (G3PDH), 9% 
(GM-CSF), or 12% (IL-6) sodium dodecylsulfate-polyacrylamide gel. Mter 
electrophoresis, autoradiography was performed using Kodak XAR-5 film. 
The relative amount of PCR products was determined by densitometric 
scanning of autoradiographs using a laser densitometer (LKB-222-020, 
UltroScan XL, Pharmacia). In some experiments, PCR was carried out 
using unlabeled primers, and the PCR products were resolved on a 1.5% 
agarose gel followed by staining with ethidium bromide. 
Southern Blotting for hIL-3 PCR-amplified eDNA was resolved on 
1.5% agarose gels and transferred to a nitrocellulose membrane, followed by 
hybridization with the e2P]-labeled human IL-3 eDNA probe. The filter 
was washed under high stringency, and autoradiography was perfonned as 
described previously [24]. 
RESULTS 
PCR amplification of cDNA produced by RT of total RNA from 
irradiated and unirradiated keratinocyte cultures was carried out 
using IL-3-specific primers from published sequences. This method 
repeatedly failed to yield any product despite increasing the cycle 
number up to 40, reamplifying the PCR product in a similar 
fashion, and increasing the concentration of target cDNA. As a 
positive control, the full-length human IL-3 insert in plasmid 
pCDSRaIL3 was coamplified and the PCR products were resolved 
by electrophoresis in an agarose gel. The products were transferred 
to a nitrocellulose filter by Southern blotting, and the filter was 
hybridized with [32P]-labeled pCDSRaIL3. Figure 1 demonstrates 
that the IL-3 probe hybridized strongly to amplified cDNA from 
pCDSRaIL3, but not to the lanes containing the products of the 
PCR amplification of cDNA from irradiated or sham-irradiated 
(unirradiated) keratinocytes. We were unable to detect any product 
in keratinocyte samples using IL-3-specific primers from Cion tech 
Laboratories (data not shown). 
To determine whether IL-3 protein was present in the keratino-
cyte cultures, we collected culture supernatants from irradiated and 
unirradiated keratinocytes and concentrated them 50-fold by ultra-
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Figure 1. Southern blotting with a [32P]_labeled human IL-3 cDNA 
probe of the PCR amplification products of cDNA reverse tran-
scribed from human keratinocytes irradiated with 300 j/m2 UVB. 
Cultures were harvested at the times indicated post-irradiation (or UI, 
unirradiated), and RNA was prepared, reverse transcribed as described in 
Materials and Methods, and amplified by PCR (40 cycles) using IL-3-specific 
primers. As a positive control, the IL-3 cDNA was amplified. The products 
were resolved on a 1.5% agarose gel and transferred to nitrocellulose. The 
filter was then probed at high stringency with the labeled human IL-3 
cDNA and exposed to XAR-5 film after washing. 
filtration before assay for IL-3 protein by IL-3 ELISA. We were 
unable to detect any IL-3 protein in the concentrated supeITlatants 
despite the high sensitivity of the ELISA (detection limit 7.4 
pg/ml). We then attempted to confirm these results by assaying the 
supeITlatants in the M-07 e bioassay. 
Figure 2 shows that supeITlatants from unirradiated keratino-
cytes contained an activity that mildly stimulated M-07 e prolifera-
tion (about 22-fold background levels). When supernatants from 
irradiated keratinocyte cultures were applied to the M-07e cells, the 
stimulation of proliferation increased about sixfold (128-fold back-
ground levels), suggesting that UVB up-regulated the production 
of cytokine(s) stimulatory for M-07e cell growth. However, neu-
tralizing antibody to IL-3 had no effect on the stimulation ofM-07e 
proliferation induced by either irradiated or unirradiated supeITla-
tants. On the other hand, incubation of the supeITlatants with 
antibody to GM-CSF reduced the proliferation by 90% in both 
irradiated and unirradiated supeITlatants. Addition of antibody to 
both GM-CSF and IL-6 completely abolished the stimulation of 
M-07e growth. This strongly suggests that the IL-3 activity pro-
duced by human keratinocytes is due to GM-CSF and IL-6, 
although neither of these cytokines is active on the FDCP-l or 
32-DCL line. 
To confirm these observations, we believed it necessary to show 
that these same keratinocyte cultures were indeed making IL-6 and 
GM-CSF RNA, as shown by other investigators [25,26]. RNA 
from the irradiated and unirradiated cultures was reverse tran-
scribed to cDNA and amplified using PCR primers specific for 
human GM-CSF and IL-6. Figure 3 presents the results of four 
different experiments showing that human keratinocytes constitu-
tively produce RNA for GM-CSF (432-bp PCR product) and that 
production of the transcript was up-regulated 2.7- to 4.3-fold at 6 
and 24 h after irradiation with UVB. Similarly, Fig 3 shows that the 
keratinocyte cultures constitutively produce RNA for IL-6, as 
shown by the presence of the 190-bp PCR product. UVB increased 
the level of the transcript 2.6- to 5.6-fold at 6 and 24 h post-
irradiation. 
In addition, we cultured normal human keratinocytes from adult 
breast skin and tried to detect IL-3 transcripts. Because many 
cytokines produced by keratinocytes are inducible, recombinant 
human IL-la (10 ng/ml) , recombinant human TNF-a (100 ngl 
ml), or PMA (10 ng/ml) was added to the culture medium for 6 h 
to stimulate keratinocytes in an exponentially growing phase. IL-3 
mRNA was not detected in normal human adult keratinocytes, and 
even after stimulation that up-regulated GM-CSF mRNA tran-
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Figure 2. IL-3-like activity in supernatants from unirradiated and 
UV -irradiated human keratinocytes and eH'ects of neutralizing 
antibodies specific for IL-3, GM-CSF, or IL-6. A) Supernatants (sups) 
from unirradiated keratinocytes contained an activity (open circles) that 
mildly stimulated M-07e proliferation (about 22-fold background levels). B) 
When supernatants from irradiated cultures were applied to the M-07e 
cells, the stimulation of proliferation increased about sixfold (128-fold of 
background levels) (open circles). Antibody to IL-3 (open triangles) had no 
effect on the stimulation of M-07 e proliferation induced by either irradiated 
or sham-irradiated supernatants. However, incubation of the supernatants 
with antibody to GM-CSF (closed circles) reduced the M-07e proliferation by 
90% in both irradiated and sham-irradiated supernatants. Addition of 
antibody to both GM-CSF and IL-6 (closed squares) completely abolished the 
stimulation of M-07e growth. 
scripts, human keratinocytes from both neonatal foreskins and adult 
skins did not express IL-3 mRNA (Fig 4). 
We also simulated the effect of contamination of keratinocyte 
cultures with other cells actively making IL-3 mRNA, which could 
1 2 3 4 5 6 7 8 C 
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Figure 3. Up-regulation of GM-CSF and IL-6 rnRNA levels in 
UV -irradiated human keratinocytes at 6 and 24 h after irradiation. 
RNA was prepared and RT-PCR was carried out using labeled primers 
specific for GM-CSF (30 cycles) or IL-6 (32 cycles) (see Materials and 
Methods), and G3PDH (20 cycles) was used as an internal control. Lanes 1 
and 2, 3 and 4, 5 and 6, and 7 and 8 were derived from four different 
individuals. Lanes 1, 3, 5, and 7 are RT-PCRs from unirradiated cultures. 
Lanes 2, 4, 6, and 8 are RT-PCRs from corresponding cultures irradiated 
and harvested at 6 h (lanes 6 and 8) and 24 h (lanes 2 and 4) post-irradiation. 
Lane C, cDNA positive control. 
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yield a false-positive result, as follows. Total RNA was extracted 
from cultures of human cutaneous T -cell lymphoma cells (HuT 78) 
stimulated with 20 JLg/ml concanavalin A. The RNA was reverse 
transcribed, and PCR was used to confirm that the HuT cells were 
expressing IL-3 rnRNA (Fig 4). A constant amount of keratino-
cyte-derived R T sample was mixed with serial dilutions of stimu-
lated HuT 78 cells-derived R T sample, and PCR was performed 
using IL-3-specific unlabeled primers (CIon tech Laboratories) for 
38 cycles. PCR products specific for IL-3 were detected in the 
keratinocyte-derived R T samples even when the T -cell- derived 
RT was diluted to 0.001% (Fig 5). About 250 JLg total RNA was 
extracted from 4 X 108 concanavalin-A-stimulated HuT 78 cells, 
and 20 JLg total RNA was extracted from 5 X 106 keratinocytes. 
Two micrograms of each was used for the R T reaction and 
reconstituted into 50 ILL Therefore, 0.001% mix of the T -cell-
derived R T into keratinocyte-derived R T represented fewer than 
10 T cells [4 X 108 X (2/250) X (2/50) X (0.001/100)] per 2 X 104 
keratinocytes [5 X 106 X (2/20) X (2/50)]. 
DISCUSSION 
The initial aim of this study was to examine whether UVB regulates 
IL-3 gene expression in normal human keratinocytes, as the 
literature contains several reports purporting to show that human 
keratinocytes and carcinoma cell lines synthesize a protein with 
IL-3-like activity [12-14,27]. Surprisingly, we were unable to 
detect IL-3 protein or IL-3 mRNA in cultured normal human 
keratinocytes even after UVB irradiation (Fig 1) or IL-la, TNF-a, 
or PMA stimulation (Fig 4). However, IL-3-like bioactivity as 
measured by the M-07e bioassay was present in keratinocyte 
culture supernatants and was increased when keratinocytes were 
irradiated with UVB (Fig 2). This bioactivity was mainly blocked 
by GM-CSF antibody and was completely abrogated by the further 
addition of IL-6 antibody (Fig 2). Our results suggest that the 
recorded IL-3-like activity is in fact principally GM-CSF with a 
small contribution from IL-6. However, this does not explain the 
stimulation ofFDCP-l and 32-DCL-23 cell proliferation by human 
keratinocyte supernatants. Another cytokine is likely present, pos-
sibly granulocyte colony-stimulating factor. 
Previous studies have shown that UVB up-regulates both IL-6 
[28] and GM-CSF [29] at both the mRNA and protein levels in 
keratinocytes (human keratinocytes for IL-6 and Pam 212 for 
GM-CSF). Our results confirm that UVB irradiation up-regulates 
IL-6 and GM-CSF mRNA levels between 6 and 24 h after 
irradiation (Fig 3). 
1 2 3 4 5 6 7 8 9 10 11 
IL-3 
G3PDH 
GM-CSF 
Figure 4. Failure to detect IL-3 mRNA in human cultured neonatal 
keratinocytes (lanes 2-5) and adult keratinocytes (lanes 6-9) after 
cytokine and phorbol ester stimulation. Total RNA was extracted 
from cultured keratinocytes after being stimulated for 6 h with recombinant 
human IL-lex (10 ng/ml) (lanes 3 and 7), recombinant human TNF-ex (100 
ng/ml) (lanes 4 and 8), or PMA (10 ng/ml) (lanes 5 and 9). RT-PCR was 
carried out using unlabeled primers specific tor IL-3 (from Clontech 
Laboratories) for 38 cycles, G3PDH for 24 cycles, and GM-CSF for 35 
cycles. PCR products were resolved on a 1.5% agarose gel and stained by 
ethidium bromide. Lane 1, DNA size marker; lane 2, unstimulated neonatal 
human keratinocytes; lane 6, unstimulated adult human keratinocytes; lane 
10, concanavalin-A-stimulated HuT 78 (human cutaneous T-cell lympho-
ma); lane 11, cDNA positive control. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
1 2 3 4 5 6 
IL-3 
Figure 5. Detection of IL-3 peR product in keratinocyte-derived 
RT samples mixed with T-cell-derived RT. Total RNA extracted 
from 24-h cultures of 20 J-Lg/ml concanavalin-A-stimulated HuT 78 cells 
(human cutaneous T cell lymphoma) was reverse transcribed, a constant 
amount ofkeratinocyte-derived RT sample was mixed with serial dilutions 
of stimulated HuT 78 cells-derived RT sample, and PCR using IL-3-
specific unlabeled primers (from Cion tech Laboratories) was carried out for 
40 cycles. PCR products specific for IL-3 (449 bp) were detected when 
keratinocyte-derived RT samples were mixed with T-cell-derived RT 
even at dilutions as low as 0.001%. Lane 1, DNA size marker; lane 2, 
neonatal human keratinocytes; lanes 3-6, HuT 78-derived RT diluted in 
keratinocyte-derived RT at the following dilutions: 1% (lane 3),0.1% (lane 
4), 0.01% (lane 5), and 0.001 % (lane 6). 
Our results are consistent with the findings of Kupper et ai, who 
were unable to demonstrate the presence of IL-3 mRNA in human 
keratinocytes (discussed in [13]). These investigators found that the 
IL-3-like activity in keratinocyte supernatants measured by the 
proliferation of the TALL 101 cell line, which responds to both 
GM-CSF and IL-3, could be neutralized by anti-GM-CSF antisera, 
which did not cross-react with IL-3 [13]. Similarly, Owsianowski et 
al [30] showed that long-term cultures of adult human keratino-
cytes as well as the spontaneously transformed keratinocyte line 
HaCaT produce GM-CSF but no IL-3 protein, as determined by 
ELISA. 
However, Dalloul et al [27] were able to show the presence of a 
1. 0 - kilobase transcript homologous to T -cell-derived IL-3 in human 
keratinocytes prepared by explant-outgrowth cultures isolated from 
adult tissue. Biologic activity (bone marrow colony-formation assay) 
was also noted, which could be inhibited by an IL-3-specific antibody. 
The reason for the discrepancy between their results and the studies 
mentioned above is not clear; some slight diH"erences in culture 
conditions could be responsible. However, we note that to see their 
IL-3 transcript by Northern blotting, they had to apply 20-60 ILg of 
RNA derived from epidermal keratinocyte cultures. Because their 
keratinocyte preparation was 94% pure, it is possible that there was 
some other cell contamination that could account for the IL-3 mRNA. 
Our results demonstrate that even minute (0.001%) contamination of 
keratinocyte RTs with IL-3-containing RTs gave PCR signals, which 
supports our speculation above. 
In a review, Luger et al [14] stated that up to that date (1988), no 
one had ever recorded the presence of IL-3 transcripts in human 
keratinocytes by Northern blotting. The putative human epidermal 
cell IL-3 was functionally defined mostly by its ability to stimulate 
proliferation of the murine 32-DCL and FDCP cell lines [11,14]. 
These same authors showed that human T -cell- derived IL-3 did 
not stimulate 32-DCL or FDCP proliferation, whereas hIL-6 did 
[14]. This was interpreted to mean that human epidermal cell IL-3 
was different from T-cell IL-3. Furthermore, the highly purified 
(single band on sodium dodecylsulfate-polyacrylamide gel electro-
phoresis) human epidermal cell IL-3 also augmented and stimulated 
natural killer cell activity as well as granulocyte-activating mediator 
activity [14]. Subsequent studies have shown that the natural killer 
cell activation is mainly due to IL-6 [31] . We interpret these results 
as suggesting that human epidermal cell IL-3 activity is probably 
due to IL-6 and some other factor, but not to authentic IL-3. 
Garland [32] also commented on the responsiveness of these cell 
lines to other cytokines by pointing out that although "IL-3 
dependency" is a widely accepted concept, in practice IL-3-
dependent cells are able to make stable responses to other growth 
factors (although, as we have shown, specificity in these assays can 
be achieved by antibody blockade). There is also the possibility that 
keratinocyte donor age aI~d culture conditions may influence the 
degree of cytokine gene expression, which could account for 
contradictory results. 
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The case for keratinocyte expression of IL-3 in the mouse is 
much stronger. Several studies have recorded the presence of a 
0.9-kilobase-pair transcript on Northern blots probed with a 
murine T-cell-derived IL-3 probe [13,14]. Gallo et al [29] showed 
that unirradiated cultures of the Pam keratinocyte cell line pro-
duced a factor that stimulated IL-3-dependent lines. Irradiation 
increased IL-3 rnRNA abundance, but not bioactivity. This activity 
could be inhibited by antibody to IL-3 [29]. R ecently, the presence 
of IL-3 mRNA was also demonstrated in normal murine neonatal 
primary cultured keratinocytes by RT -PCR, and activity in the 
supernatants could be neutralized with antibody to murine IL-3 [33]. 
We believe that given the sensitivity of the PCR approach-
sufficient to detect cytokine rnRNA in as few as 16-4000 cells 
[34 ]-it is probable that if the keratinocyte IL-3 is not detectable at 
40 cycles, it is either not there or the cytokine is not homologous to 
T-cell IL-3 and may not be amplified by our primers. Taken 
together, our PCR, ELISA, and bioassay data suggest that under 
standard culture conditions human keratinocytes do not express IL-3. 
Both the IL-3 and GM-CSF genes are located on chromosome 5. 
In the 5' flanking sites of these genes, there are several common 
enhancer regions containing cis-acting DNA sequences, i.e ., the 
conserved lyrnphokine element and a GC-rich region [35]. Nishida 
et al [36] proposed that the GM-CSF enhancer conserved lympho-
kine element 2/GC box, which mediates the response to T - cell 
activation signals, may stimulate expression of the IL-3 gene . 
However, normal and neoplastic B lymphocytes have been shown 
to express and produce GM-CSF, but not IL-3 [3 7] . The same 
phenomenon has been observed in bone marrow stromal fibroblasts 
[38]. Furthermore, a significant difference between GM-CSF and 
IL-3 in signal requirements for their gene expression has been 
observed in T cells [39]. Our results, together with these observa-
tions, suggest that IL-3 and GM-CSF gene expression may be 
regulated in a tissue-specific manner. 
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